The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

Unlike existing benzodiazepine-hypnotic sleep medications, melatonin analogs have shown no tendency toward addiction or dependence. Melatonin supplements are available over the counter and ...

Both studies monitored obese adults with moderate to severe sleep apnea over a 52-week period ... follows a series of other weight loss drugs approved to treat medical conditions other than ...

Because sleep apnea is an anatomic disorder, drugs typically have not been effective, Schwab says. But the new GLP-1 weight ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the ... 45 ...

The agency green-lit the blockbuster medication to treat moderate to severe obstructive sleep apnea in adults with ... the FDA officially declared the shortage over, a long-sought victory for ...

The Barometer surveyed 1,150+ global healthcare providers across specialties on their experience prescribing weight loss medications. In addition to sleep apnea ... For over 20 years, Sermo ...